Why BGPT?
logo

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Press Enter ↡ to search evidence



    Explore by Goal











     Long Response


    Create Graphs (from provided paper data): Trial phase + Target distribution
    Used sources (raw distributions explicitly provided in your dataset):
    • Trial phase distribution from a registry-based analysis of digestive-system cancer vaccine trials: 10.2147/CMAR.S561298
    • Target distribution from a registry-based analysis of the global CAR-T trial landscape (top targets): 10.1186/s40364-026-00910-6
    Note: The provided excerpts include trial phase counts for the cancer vaccine review, and target rankings for the CAR‑T review. The CAR‑T excerpt does not provide phase-by-phase counts, and the cancer-vaccine excerpt does not provide a complete numeric target histogramβ€”so the graphs below use only what is explicitly available.
    The excerpt specifies the top target names (e.g., CD19, TNFRSF17, CD22…) but does not provide the numeric target frequencies needed for a true count plot. The bar heights above are used only to present an ordered β€œtop list” view; they are not trial counts.
    Evidence notes & limitations (skeptical reading)
    • Trial phase plot uses explicitly provided phase counts (Phase I, Phase I/II, Phase II, Late-stage) from a registry-based analysis of interventional digestive-cancer vaccine trials. The excerpt does not provide late-stage phase breakdown beyond a single β€œlate-stage” bucket.
    • CAR‑T status plot uses explicit trial-status percentages (ongoing/planned/completed/terminated/closed) from a global CAR‑T trial landscape analysis based on INFORMA data and deduplication to 1,908 trials.
    • CAR‑T target β€œtop list” plot shows target names only; no numeric frequencies were provided in the excerpt. Therefore, the visualization cannot support claims about relative prevalence by target.
    • Registry-based summaries can be affected by coverage limits, reporting changes over time, and registry-specific indexing/deduplication rules. The excerpt explicitly notes reliance on single registries and lack of public deposition of underlying trial-level data.
    • For the vaccine-trial phase plot, the excerpt similarly indicates descriptive, registry-based meta-analytic framing and potential reporting bias.


    Feedback:    

    Updated: April 30, 2026

     Top Data Sources ExportMCP


     Analysis Wizard



    This will parse the provided paper excerpts into phase and target category counts, then generate Plotly-ready arrays for publication-quality bar charts without introducing new assumptions.



     Science Art


    Create Graphs: Plot trial phase and target distribution from paper Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending